← Back to Patent Explorer
US5030637A Expired / Lapsed US ⏱️ 0.0 years remaining

Anisodamine to prevent and treat eye disease

Assignee: University of Minnesota System
•
Filing: 1990-09-10
•
Granted: 1991-07-09
•
Expires: 2010-09-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method is disclosed for the prevention and alleviation of pathologic changes in the eye such as diabetic retinopathy or senile macular degeneration. The claimed method involves the parenteral administration of anisodamine in an amount effective for preventing or alleviating these pathogenic changes.

Inventors

  • 👤 Stanley Einzig
  • 👤 Shu-Lun Zhang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 09:08
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/46

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 39 words
A method for protecting the eye against senile macular degeneration comprising administering anisodamine or a pharmaceutically-acceptable salt thereof to the eye of a human in need thereof in an amount effective to protect the eye against senile macular degeneration.
Claim 2
Independent Claim 39 words
A method for protecting the eye against senile macular degeneration comprising administering anisodamine or a pharmaceutically-acceptable salt thereof to the eye of a human in need thereof in an amount effective to protect the eye against senile macular degeneration.
Claim 3
Dependent Claim 22 words
The method of claim 1 wherein anisodamine or the pharmaceutically-acceptable salt thereof is parenterally administered in association with a pharmaceutically-acceptable liquid carrier.
Claim 4
Dependent Claim 20 words
The method of claim 1 wherein the effective amount administered is about 0.5-50 mg per kilogram body weight, per day.
Claim 5
Dependent Claim 10 words
The method of claim 1 wherein anisodamine is topically administered.
Claim 6
Dependent Claim 14 words
The method of claim 1 wherein anisodamine is administered in the form of eyedrops.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-07-08 1995-01-07 1995-07-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-07-08 1999-01-07 1999-07-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-07-08 2003-01-07 2003-07-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag